Hospital Alemão Oswaldo Cruz
18
5
6
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
16.7%
3 terminated/withdrawn out of 18 trials
66.7%
-19.8% vs industry average
33%
6 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Leprosy Active Searching Trial in Brazil
Role: lead
Organosilane for Surface Cleaning in Intensive Care Units
Role: collaborator
BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
Role: lead
Implementation of the START Intervention in Brazil: a Controlled Feasibility Trial
Role: lead
Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation
Role: collaborator
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait
Role: lead
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
Role: collaborator
Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population
Role: lead
Local Excision for Organ Preservation in Early REctal Cancer With No Adjuvant Treatment
Role: collaborator
COVID-19 Antithrombotic Rivaroxaban Evaluation
Role: lead
Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19
Role: collaborator
Quality of Life and Long-term Outcomes After Hospitalization for COVID-19
Role: collaborator
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)
Role: lead
Evaluation of Chest Wall Motility After MIRPE
Role: collaborator
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
Role: collaborator
Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
Role: lead
Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus
Role: lead
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Role: collaborator
All 18 trials loaded